205 related articles for article (PubMed ID: 15142045)
1. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.
Sawada T; Fuchinoue S; Kawase T; Kubota K; Teraoka S
Clin Transplant; 2004 Jun; 18(3):254-60. PubMed ID: 15142045
[TBL] [Abstract][Full Text] [Related]
2. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
3. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to successful ABO-incompatible high-titer renal transplantation.
Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T
Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
6. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
7. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N
Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272
[TBL] [Abstract][Full Text] [Related]
8. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
[TBL] [Abstract][Full Text] [Related]
9. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
10. Immunization by blood-type antigen in human immunoglobulin products before ABO-incompatible kidney transplantation.
Sawada T; Ando T; Sato S; Kubota K; Fuchinoue S; Teraoka S
Clin Transplant; 2004 Apr; 18(2):219-21. PubMed ID: 15016140
[TBL] [Abstract][Full Text] [Related]
11. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
[TBL] [Abstract][Full Text] [Related]
12. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with ABO-incompatible live donor renal transplantation.
Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
[TBL] [Abstract][Full Text] [Related]
14. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
15. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K
Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
[TBL] [Abstract][Full Text] [Related]
16. Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis.
Ishikawa A; Itoh M; Ushlyama T; Suzuki K; Fujita K
Clin Transplant; 1998 Apr; 12(2):80-3. PubMed ID: 9575393
[TBL] [Abstract][Full Text] [Related]
17. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns.
Saliba F; Ichaï P; Azoulay D; Habbouchi H; Antonini T; Sebagh M; Adam R; Castaing D; Samuel D
Ther Apher Dial; 2010 Feb; 14(1):116-23. PubMed ID: 20438529
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange conditioning for ABO-incompatible renal transplantation.
Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
[TBL] [Abstract][Full Text] [Related]
20. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab.
Tydén G; Kumlien G; Fehrman I
Transplantation; 2003 Aug; 76(4):730-1. PubMed ID: 12973118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
